National Pharmacies Revenue and Competitors
Estimated Revenue & Valuation
- National Pharmacies's estimated annual revenue is currently $141.9M per year.
- National Pharmacies's estimated revenue per employee is $283,750
Employee Data
- National Pharmacies has 500 Employees.
- National Pharmacies grew their employee count by 2% last year.
National Pharmacies Competitors & AlternativesAdd Company
| Competitor Name | Revenue | Number of Employees | Employee Growth | Total Funding | Valuation |
|---|---|---|---|---|---|
#1 | $12.3M | 60 | N/A | N/A | N/A |
#2 | $6.7M | 37 | N/A | N/A | N/A |
#3 | $18.4M | 81 | 7% | N/A | N/A |
#4 | $27.7M | 122 | 27% | N/A | N/A |
#5 | $24.5M | 108 | 7% | N/A | N/A |
#6 | $60.4M | 242 | 7% | N/A | N/A |
#7 | $65.7M | 263 | N/A | N/A | N/A |
#8 | $24.5M | 108 | 6% | N/A | N/A |
#9 | $6.7M | 37 | -36% | N/A | N/A |
#10 | $58.4M | 234 | -7% | N/A | N/A |
What Is National Pharmacies?
National Pharmacies is a well known and highly respected South Australian based organisation, which has been caring for the community since 1911. National Pharmacies is the trading name of the Friendly Society Medical Association Limited. We are a mutual organisation where profits made through our operations are returned to our members in the form of benefits and discounts. pharmaceuticals, Optical, Hearing
keywords:N/A
N/A
Total Funding
500
Number of Employees
$141.9M
Revenue (est)
2%
Employee Growth %
N/A
Valuation
N/A
Accelerator
National Pharmacies News
By ZAC MILBANK. The 2022 National Pharmacies SANFL Juniors season will kick off this weekend with Round 1 matches to be played on Friday...
Whereas telehealth use expanded in pharmacy over the pandemic, pharmacy ... Several national pharmacy associations have recently adopted...
Biden will make Paxlovid, a highly effective COVID drug, available to more pharmacies ... President Biden is seen delivering remarks on COVID-19...
Other Companies in
| Company Name | Revenue | Number of Employees | Employee Growth | Total Funding |
|---|---|---|---|---|
#1 | $81.3M | 500 | 4% | N/A |
#2 | $35M | 500 | 8% | N/A |
#3 | $35M | 500 | -3% | N/A |
#4 | $90.8M | 501 | 1% | N/A |
#5 | $182M | 502 | 7% | N/A |